Oncology Portfolio Articles & Analysis
3 articles found
The partnership builds on an existing collaboration between AngioDynamics and Cardiva, which has seen the successful distribution of AngioDynamics’ vascular access portfolio in Spain and Portugal since 2012. The expanded partnership will now include AngioDynamics’ oncology portfolio, with the addition of the Italian market in the ...
We’re also condensing the time it takes to translate insights from our maps of biology into potential new medicines. Programs in our pre-clinical oncology portfolio, for example, have advanced from initial hit to in vivo studies in a matter of months. ...
It provides access to a comprehensive collection of well-established tumor models for early-stage oncology research and increases their translational capabilities to the clinic. ...